Skip to main content
. 2016 Aug 22;113(36):10139–10144. doi: 10.1073/pnas.1600112113

Table S1.

Expression levels of surface markers on cNK and IL4-NK cells

Markers cNK cells IL4-NK cells
Common NK marker
 CD49b** 180.0 ± 6.1 86.1 ± 2.5
Maturation markers
 B220* 20.2 ± 2.0 145.3 ± 17.4
 CD11b*** 189.7 ± 1.9 27.5 ± 2.4
 TRAIL 6.0 ± 0.7 5.1 ± 0.6
Activating receptors
 NK1.1* 491.2 ± 21.4 720.0 ± 53.1
 NKp46* 325.7 ± 21.5 222.3 ± 26.0
 NKG2D 35.6 ± 0.8 27.2 ± 4.6
 2B4* 209.0 ± 16.4 681.3 ± 59.1
 Ly108** 9.3 ± 0.8 24.7 ± 2.4
Inhibitory receptors
 KLRG1 161.0 ± 33.0 73.2 ± 16.8
 NKG2A*** 30.6 ± 0.8 11.1 ± 0.3
Activation marker
 Thy1.1** 294.3 ± 89.1 963.5 ± 133.9
Resting marker
 Ly6C** 106.5 ± 11.2 28.6 ± 5.4
Cytokine receptors
 IL-4Rα* 10.1 ± 0.9 31.0 ± 4.9
 IL-7Rα 5.3 ± 1.1 4.6 ± 0.1
 IL-18Rα* 26.6 ± 4.0 5.0 ± 0.3
 IL-21Rα** 4.5 ± 0.3 17.4 ± 0.9

The cNK cells in the liver were derived from the mice at 5 d after the injection with control vector (5 μg). The IL4-NK cells in the liver were derived from the mice at 5 d after the injection with pLIVE-IL-4 vector (5 μg). The numbers indicated MFI ± SEM of at least three separate experiments. *P < 0.05; **P < 0.01; ***P < 0.001.